We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Kriya Therapeutics, Inc. today announced the completion of the renovation of its 51,000 square foot facility located in Research Triangle Park, North Carolina to support cGMP production of its expanding pipeline of gene therapies.
Kriya announced the closing of a $100 Million Series B financing to support its mission of transforming the design, development and manufacturing of gene therapies.